Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
202 participants
INTERVENTIONAL
2011-11-30
2015-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study is possible thanks to surgical teams who have a strong recruitment potential, with the experience of a joint project in 2007-2008 (PHRC national - Etude DOREMY, Etude FRIENDS) to define more strict intervention criteria. The principal objective of this study is to better define with regard to time:
* The onset of surgically curable or transient macular affections, and losses in visual acuity that can be qualified as "explained"
* But above all to better understand the relationships between anatomical analyses obtained using OCT and autofluorescence and functional analysis using visual acuity and microperimetry.
* In the near future, two techniques (OCT and microperimetry) will certainly become essential tools in the evaluation of macular function. Better understanding of these relationships is the first necessary step in any study concerning the therapeutic prevention of retinal lesions related to retinal detachment: This study will make it possible to define criteria for the evaluation of anatomical and functional recovery, their relationship with each other and finally their evolution over time. This is an essential first phase before possible therapies can be evaluated.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
OCT Spectralis
microperimetry
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Retinal detachment with pre-operative raised macula, re-attached during a surgical intervention with one month of follow-up
* Patients undergoing surgery as the first-line treatment (ab extern surgery or gas vitrectomy)
* Patients who accept to be followed for at least 12 months at the investigating center.
Exclusion Criteria
* Macular affections pre-existent to the DR
* Retinal detachment requiring several interventions to obtain a reapplication
* Lazy eye with pre-operative
* Brightness of the circles not allowing the realization of the examinations
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire Dijon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Besançon
Besançon, , France
CHU Bordeaux
Bordeaux, , France
CHU Dijon
Dijon, , France
CHU Grenoble
Grenoble, , France
CHU Nancy
Nancy, , France
CHU Nantes
Nantes, , France
Hôpital Lariboisière
Paris, , France
Fondation Ophtalmologique Adolphe de Rothschild
Paris, , France
CHU Reims - Hôpital Robert Debré
Reims, , France
CHU Strasbourg - Hôpital Civil
Strasbourg, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Creuzot-Garcher PHRC N 2010
Identifier Type: -
Identifier Source: org_study_id